Researchers have developed an intelligent surgical knife that can help doctors identify if a tissue being cut is of cancerous nature or not, in turn enabling an accurate surgery. The knife, created by London's Imperial College ...
Tags: UK Researchers, Surgical Knife
Clinical stage biopharma company Rexahn Pharmaceuticals has entered into an exclusive licensing agreement with the University of Maryland, Baltimore (UMB), for a novel drug delivery platform, which targets the delivery of chemotherapeutic ...
Tags: Rexahn Pharma, Oncology Drug
The US Food and Drug Administration (FDA) has cleared Boehringer Ingelheim's tyrosine kinase inhibitor Gilotrif (afatinib) as a new medication for patients with late stage (metastatic) non-small cell lung cancer (NSCLC). The approval also ...
Tags: FDA, Lung Cancer Therapy, Medicine
Healthcare products provider Covidien has announced that the results from SUrveillance vs. RadioFrequency ablation (SURF) trial showed that the endoscopic ablation therapy using the Barrx RF Ablation System eliminates Barrett's esophagus, a ...
Tags: Covidien, Barrx Rf Ablation System
Chindex Medical and Medvio have entered into a collaboration agreement with an advanced imaging and radiation therapy technologies provider iCAD. Under the agreement, Chindex will distribute iCAD's Xoft Axxent Electronic Brachytherapy ...
Tags: Medvio, Chindex Medical, Medicine
The US Food and Drug Administration (FDA) has approved a new drug named Pomalyst (pomalidomide) for patients who received and did not respond to prior cancer therapies. Pomalyst, the third drug in a class of immunomodulatory agents ...
A new phenotyping research centre in London aims to help doctors diagnose illness more efficiently and choose the best treatments for patients based on their individual metabolic and physiological characteristics. The Imperial Clinical ...
Tags: phenotyping research centre, London, illness
US gastrointestinal endoscopy company EndoChoice has purchased German-based endoscope manufacturer RMS Endoskopie-Technik. Under the acquisition, Full Spectrum Endoscope, a portfolio product of Peer Medical which is now merged with ...
Tags: EndoChoice, RMS Endoskopie-Technik, purchase, endoscope
US gastrointestinal endoscopy company EndoChoice will merge with an Israeli company Peer Medical for an undisclosed sum. Peer Medical's commercial products include a proprietary video system and Full Spectrum Endoscope which provides up ...
Tags: gastrointestinal endoscopy, EndoChoice, video system, cancerous
Dune Medical Devices' MarginProbe system, designed for the detection of breast cancer, has obtained premarket approval (PMA) from the US Food and Drug Administration (FDA). The system is an intra-operative tissue assessment tool which ...
Tags: Dune Medical, FDA Approval, Breast Cancer Detection Device, Medicine
MIT researchers are using nanotechnology to help doctors detect cancer in their patients sooner, increasing their odds of beating the disease. To diagnose cancer, doctors look for specific proteins secreted by cancer cells. The problem ...
Tags: MIT, nanotechnology, detect cancer, specific proteins
Enzo Biochem's Clinical Labs has launched a new diagnostic test, designed to assess and detect lung cancer at earlier stages, in New York metropolitan market as well as New Jersey and Eastern Pennsylvania, US. Using a panel of tumor ...
Tags: Enzo Biochem, diagnostic test, EarlyCDT-Lung test, EarlyCDT-Lung
Ledford Medical Electronics has entered into an agreement to expand the sales of Naviscan's organ-specific PET Scanner for use in breast applications in the US. The company said the breast application of the scanner is known as Positron ...
Tags: Ledford Medical, agreement, expand sales, PET Scanner, breast application
Thermedical has obtained 510(k) clearance for its radiofrequency-based thermal ablation system, designed for treating large volumes of solid tumors, from the US Food and Drug Administration (FDA). Featuring a single or more needles, the ...
Tags: Thermedical, thermal ablation system, FDA, radiofrequency waves, approval
Mauna Kea Technologies has obtained CE mark for its UroFlex confocal miniprobe, designed for use in urological applications. The optical biopsy probe, the first urological probe in the Cellvizio portfolio, provides physicians with an ...
Tags: Mauna Kea Technologies, CE mark, TURBT